StockWatch
·

Manorama Industries Ltd

BSE: 541974

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
419.99
+11.4%+42.5%
Expenditure
310.77
+4.9%+37.8%
Net Profit
81.59
+37.1%+61.3%
OPM %
27.04%
+0.14pp-0.23pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00117.60235.19352.79470.38Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Volume Surge Carries Margins; One-Time Forex Gain Flatters Reported Profit

specialty-fats · volume-growth · capex-roadmap

Result verdictFollow-upQ1 FY2718 Aug 20266 minFMCG

Strong volume growth corroborated; long-term capex positioned, margins guarded

volume-led growth · capacity expansion · specialty ingredients

TranscriptDeep diveQ1 FY2718 Aug 20266 minFMCG

Manorama Q1FY27: consol PAT surges 67.5% YoY to ₹78.7 Cr, margins expand on 39.5% growth

specialty fats and butters · cocoa butter equivalent · margin expansion

ResultsQ1 FY2713 Aug 20263 minFMCG
Latest
Quarterly Result13 Aug, 6:30 pm

Manorama Q1FY27: consol PAT surges 67.5% YoY to ₹78.7 Cr, margins expand on 39.5% growth

Manorama Industries' consolidated Q1 FY27 (quarter ended June 30, 2026) revenue rose 39.5% YoY to ₹404.0 Cr, crossing the ₹400 Cr quarterly mark for the first time, while consolidated PAT grew 67.5% YoY to ₹78.7 Cr — profit outpacing revenue, with NPM expanding to 18.7% from 15.9% a year ago. No exceptional items were recorded in either statement this quarter, so the growth is organic. Standalone PAT of ₹81.6 Cr (+61.3% YoY) ran slightly ahead of the consolidated print; the nine overseas subsidiaries (Nigeria, Dubai, Togo, Brazil, Ghana, Burkina Faso, Ivory Coast, Benin) posted a combined net loss of ₹2.93 Cr this quarter, narrower than the ₹3.63 Cr loss a year ago — which is why consolidated PAT actually grew faster than standalone, a >3pp divergence in growth rate worth flagging even though both bases tell a strong-quarter story. Operating (EBITDA) margin came in at roughly 26.3% of revenue, up from 25.8% a year ago and sitting inside management's guided 25-27% EBITDA band from the January 2026 concall, when the company also raised its FY26 revenue guidance to ₹1,300 Cr from ₹1,150 Cr — a target it went on to beat, closing FY26 at ₹1,366.7 Cr. Other income of ₹16.2 Cr (more than triple the ₹5.8 Cr a year ago, largely mark-to-market FX gains per the filing's own notes) added to the PBT print; stripping it out, operating PBT still grew a healthy ~51% YoY, so the beat is not primarily an other-income effect. Sequentially, revenue was up a modest ~3% versus the March-quarter print, consistent with this being a non-seasonal specialty-ingredients business rather than a QoQ-driven story. No fresh FY27 guidance was on record at filing time, and no street/consensus estimate specific to this quarter turned up in a search, so vsStreet is marked unknown; the closest available yardstick is the company's own EBITDA-margin guidance, which this quarter's ~26.3% operating margin is tracking within band. Management's own framing credits the print to "sustained demand across key end-user industries, deeper customer engagement, and the growing contribution of our value-added specialty fats and butters portfolio" — consistent with the margin expansion in the numbers. Two developments sit outside this quarter's P&L: the company paid ₹20.64 Cr in customs duty on August 10, 2026 following a customs inquiry (with a separate clarification filed on a disclosure-timing question), not booked as an exceptional item in this statement; and the board set September 14, 2026 as the record date for a final dividend and incorporated a new wholly-owned subsidiary in Chad on July 21, 2026, extending the African sourcing base underpinning the CBE/specialty-fats business.

13 Aug 2026, 06:30 pm

Corporate Events

DividendMANORAMA
2026
14Sep

Dividend

BSE Filing
Board MeetingMANORAMA
2026
13Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing
Board MeetingMANORAMA
2026
9Jul

Board Meeting

The Board of Directors considered and approved the incorpora…

BSE Filing
Board MeetingMANORAMA
2026
29Jun

Board Meeting

The Board considered and approved the preliminary placement …

BSE Filing
Board MeetingMANORAMA
2026
11May

Board Meeting

The Board of Directors of the Company considered and approve…

BSE Filing
Board MeetingMANORAMA
2026
12Mar

Board Meeting

To consider and evaluate a proposal for raising funds by way…

BSE Filing
Board MeetingMANORAMA
2026
1Jan

Board Meeting

Trading Window closure

BSE Filing
Board MeetingMANORAMA
2025
17Oct

Board Meeting

Approve the Unaudited Standalone and Consolidated Financial …

BSE Filing
Board MeetingMANORAMA
2025
1Jul

Board Meeting

Trading Window Closure

BSE Filing
Board MeetingMANORAMA
2024
23Oct

Board Meeting

consider and approve the Unaudited Financial Results (Standa…

BSE Filing
Board MeetingMANORAMA
2024
30Jul

Board Meeting

consider and approve Unaudited Financial Results for the qua…

BSE Filing
Board MeetingMANORAMA
2024
12May

Board Meeting

Approval of Audited Standalone Financial Results for the qua…

BSE Filing
Stock SplitMANORAMA
2024
8Mar

1:5

BSE Filing
Board MeetingMANORAMA
2024
10Feb

Board Meeting

Consider and approve unaudited financial results for the qua…

BSE Filing
Board MeetingMANORAMA
2024
15Jan

Board Meeting

consider and approve the proposal to Sub-Division /Split of …

BSE Filing
Board MeetingMANORAMA
2023
9Nov

Board Meeting

Consider and approve Intimation for Board Meeting for approv…

BSE Filing